Innovative Therapies for Alzheimer’s Disease
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
In the US alone, Alzheimer’s disease healthcare costs are projected to increase from $200 billion in 2013 to $1.2 trillion by 2050. Thus, the lack of good treatment options for AD creates a heavy personal, societal and financial burden. In response to these challenges, researchers have undergone an intense search for new and more effective treatments.
The most promising of these are the disease-modifying agents which focus on reducing CNS levels of β-amyloid and its related aggregated structures In our coverage of the nine major pharmaceutical markets (i.e. US, UK, France, Germany, Italy, Spain, Japan, China, Brazil) we forecast that the AD market will grow from $5.7 billion in 2012 to $19 billion by 2022, making it one of the fastest growing disease areas in the industry.
In this report Peter Alfinito Ph.D reports on the latest research on the growth areas in this market and the therapies which will shape it. Download now to discover Innovative Therapies for Alzheimer’s Disease